Nikko Asset Management Americas, Inc. Crispr Therapeutics Ag Transaction History
Nikko Asset Management Americas, Inc.
- $8.64 Billion
- Q3 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,967,219 shares of CRSP stock, worth $154 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
2,967,219
Previous 3,151,514
5.85%
Holding current value
$154 Million
Previous $170 Million
18.09%
% of portfolio
1.61%
Previous 1.99%
Shares
25 transactions
Others Institutions Holding CRSP
# of Institutions
499Shares Held
56.8MCall Options Held
1.7MPut Options Held
1.8M-
Capital International Investors Los Angeles, CA7.87MShares$408 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$389 Million3.35% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$154 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$144 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.73MShares$142 Million0.09% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.05B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....